Bellevue Group AG - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$12,145,320
-33.0%
294,432
-9.3%
0.20%
-24.3%
Q2 2023$18,133,817
+0.1%
324,7460.0%0.26%
-1.5%
Q1 2023$18,117,579
+53.1%
324,7460.0%0.26%
+67.5%
Q4 2022$11,833,744
+63.5%
324,746
+27.8%
0.16%
+51.0%
Q3 2022$7,238,000
-38.3%
254,134
-2.0%
0.10%
-37.3%
Q2 2022$11,737,000
-39.0%
259,371
+2.6%
0.17%
-25.6%
Q1 2022$19,235,000
-44.5%
252,859
+8.7%
0.22%
-37.5%
Q4 2021$34,659,000
+2.3%
232,6720.0%0.36%
+3.8%
Q3 2021$33,872,000
-25.7%
232,6720.0%0.34%
-22.7%
Q2 2021$45,562,000
+9.9%
232,672
+1.6%
0.44%
+1.4%
Q1 2021$41,456,000
+77.3%
229,039
+38.7%
0.44%
+63.8%
Q4 2020$23,381,000
+21.8%
165,123
+7.2%
0.27%
+1.1%
Q3 2020$19,199,000
+74.7%
153,989
+25.1%
0.26%
+69.9%
Q2 2020$10,992,000
+87.9%
123,077
+31.1%
0.16%
+38.1%
Q1 2020$5,849,000
-40.6%
93,847
-27.3%
0.11%
-27.6%
Q4 2019$9,846,000
+95.4%
129,127
+29.1%
0.16%
+66.0%
Q3 2019$5,040,000100,0000.09%
Other shareholders
10X GENOMICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 1,358,528$49,504,760100.00%
Meritech Capital Associates V L.L.C. 1,061,682$38,687,6929.44%
Decheng Capital Management III (Cayman), LLC 359,554$13,102,1484.90%
Sands Capital Ventures, LLC 481,770$17,5564.81%
Whitford Management LLC 58,310$2,124,8032.88%
FINANCIAL CONSULATE, INC 156,457$5,701,2931.99%
SRS Investment Management, LLC 3,005,427$109,517,7601.98%
BRANDYWINE MANAGERS, LLC 11,208$408,4201.43%
ARK Investment Management 4,316,567$157,295,7011.36%
Nikko Asset Management Americas, Inc. 2,177,988$79,365,8831.14%
View complete list of 10X GENOMICS INC shareholders